FORM 4 Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL OMB Number: 3235-0287 Expires: January 31, 2005 Estimated average burden hours per response... 0.5

(Print or Type Responses)

1. Name and Address of Reporting Person * POLEWACZYK JAMES F   2. Issuer Name and Ticker or Trading Symbol IDEXX LABORATORIES INC /DE [IDXX] 5. Relationship of Reporting Person(s) to Issuer (Check all applicable) _____ Director _____ 10% Owner __X__ Officer (give title below) _____ Other (specify below) Corporate Vice President (Last) (First) (Middle) ONE IDEXX DRIVE 3. Date of Earliest Transaction (Month/Day/Year) 02/14/2013 (Street) WESTBROOK, ME 04092 4. If Amendment, Date Original Filed(Month/Day/Year) 6. Individual or Joint/Group Filing(Check Applicable Line) _X_ Form filed by One Reporting Person ___ Form filed by More than One Reporting Person (City) (State) (Zip) Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned

1.Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4) Code V Amount (A) or (D) Price Common Stock 02/14/2013   M   186 A $ 0 6,287 (1) D   Common Stock 02/14/2013   M   194 A $ 0 6,481 D   Common Stock 02/14/2013   M   281 A $ 0 6,762 D   Common Stock 02/14/2013   M   400 A $ 0 7,162 D   Common Stock 02/14/2013   M   257 A $ 0 7,419 D   Common Stock 02/14/2013   F   464 D $ 91.68 6,955 D

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
	Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.		SEC 1474 (9-02)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)

1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4, and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Underlying Securities (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Non-Qualified Stock Option (right to buy)	$ 91.68	02/14/2013		A		8,222		(2)	02/13/2020	Common Stock	8,222	$ 0	8,222	D
Incentive Stock Option (right to buy)	$ 91.68	02/14/2013		A		1,090		(3)	02/13/2020	Common Stock	1,090	$ 0	1,090	D
Restricted Stock Unit	(4)	02/14/2013		A		900		(4)	(4)	Common Stock	900	$ 0	4,502	D
Restricted Stock Unit	(5)	02/14/2013		M			186	(5)	(5)	Common Stock	186	$ 0	4,316	D
Restricted Stock Unit	(6)	02/14/2013		M			194	(6)	(6)	Common Stock	194	$ 0	4,122	D
Restricted Stock Unit	(7)	02/14/2013		M			281	(7)	(7)	Common Stock	281	$ 0	3,841	D
Restricted Stock Unit	(8)	02/14/2013		M			400	(8)	(8)	Common Stock	400	$ 0	3,441	D
Restricted Stock Unit	(9)	02/14/2013		M			257	(9)	(9)	Common Stock	257	$ 0	3,184	D

Reporting Owners

Reporting Owner Name / Address	Relationships
	Director	10% Owner	Officer	Other
POLEWACZYK JAMES F ONE IDEXX DRIVE WESTBROOK, ME 04092			Corporate Vice President

Signatures

Conan R. Deady, Attorney-in-Fact for James F. Polewaczyk		02/19/2013
**Signature of Reporting Person		Date

Explanation of Responses:

*	If the form is filed by more than one reporting person, see Instruction 4(b)(v).
**	Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
(1)	Includes 45 shares and 55 shares acquired under the IDEXX Laboratories, Inc. Employee Stock Purchase Plan on 09/30/2012 and 12/31/2012, respectively.
(2)	Grant of options to buy shares of common stock becomes exercisable as to 1,863 shares on 02/14/2014 and 02/14/2015, 1,862 shares on 02/14/2016 and 02/14/2017, and the remaining 772 shares on 02/14/2018.
(3)	Grant of options to buy shares of common stock that vest on the fifth anniversary date (02/14/2018) of the grant.
(4)	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2014) of the date of grant.
(5)	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2013) of the date of grant.
(6)	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2012) of the date of grant.
(7)	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2011) of the date of grant.
(8)	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2010) of the date of grant.
(9)	Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. The restricted stock units vest in five equal annual installments, beginning on the first anniversary date (02/14/2009) of the date of grant.

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.

Potential persons who are to respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB number.